COMPARE · Reviewed August 3, 2026
IMAX vs NYT
Verdict: Side-by-side breakdown using the Bull Rankings model. IMAX scored 63.8, NYT scored 63.2 — IMAX leads.
Compare another set
Different reporting periods. IMAX's fundamentals are as of June 2026, but NYT's are as of March 2026 — a 3-month gap. Growth, margin and valuation figures below therefore describe different windows and aren't strictly like-for-like.
IMAX
IMAX Corporation
63.8
$50.70 · $2.8B
fundamentals as of
Score gap
0.6
IMAX leads
NYT
The New York Times Company
63.2
$75.40 · $12.2B
fundamentals as of
The model, pillar by pillar (0–100 each)
IMAX
stronger →← stronger
NYT
73
Qualityreturns · margins · balance sheet
83
89
Growthrevenue & earnings expansion
82
39
Valuevaluation vs sector peers
37
IMAX is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
IMAX
NYT
$127mC
FCF
$542mC+
+14.8%B+
Rev
+10.4%B
0.63B
D/E
0.02A
69.5xC
P/E
32.4xC+
0.93B+
PEG
3.79D
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
IMAX
NYT
22% above
Price vs fair valuelower is cheaper
19% above
~13%/yr
Growth the price implies10-yr FCF · lower = less priced in
~12%/yr
-27%
1-yr DCF upside
-25%
-18%
5-yr DCF upside
-16%
-3%
10-yr DCF upside
-1%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
IMAX
No notable signals flagged.
NYT
Why this score
- Raising its dividend
The companies
IMAXIMAX Corporation
Why now
Entertainment · market cap $2.8b. Trading near 52-week high of $51.30 — momentum setup, limited technical margin of safety. Revenue growing +15%, comfortably above the S&P median. PEG 0.93 — paying under fair value for the growth rate. 11 sell-side analysts rate this a Buy with a mean 1-yr target of $50.27 (implying -1% upside).
Moat
ROE 12% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trailing P/E 69.5x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Trading within 1% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction.
NYTThe New York Times Company
Why now
Publishing · market cap $12.2b. 13% off the 52-week high of $87.10. Revenue growing +10%, comfortably above the S&P median. 9 sell-side analysts publish a mean 1-yr target of $83.44 (implying +11% upside).
Moat
Net margin 13% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 19% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 142% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trailing P/E 32x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.